Scientists discovered how a ketogenic diet (high fat, low carb) may help fight colorectal cancer. When you eat a ketogenic diet, your body produces a chemical called beta-hydroxybutyrate instead of using glucose for energy. Researchers found that this chemical sends a signal to cancer cells that tells them to stop growing. The signal works by changing a protein called RagC, which controls whether cancer cells can grow or not. This discovery could lead to new ways to treat colorectal cancer by combining diet with other treatments. The research was tested in mice and human cancer samples with promising results.
The Quick Take
- What they studied: How a ketogenic diet produces a chemical that stops cancer cells from growing by changing how a specific protein works inside cells
- Who participated: Laboratory mice with a specific genetic change, plus human colorectal cancer tissue samples grown in the lab
- Key finding: A chemical called beta-hydroxybutyrate (made when eating a ketogenic diet) attaches to a protein called RagC and turns off the mTORC1 pathway, which is like the ‘growth switch’ for cancer cells
- What it means for you: This research suggests that a ketogenic diet might help slow colorectal cancer growth, but it’s still in early stages. This is not a replacement for standard cancer treatment—talk to your doctor about whether this could be part of your treatment plan
The Research Details
Researchers used laboratory mice that were genetically modified to study how beta-hydroxybutyrate affects cancer growth. They also tested the findings using actual human colorectal cancer tissue samples grown in lab dishes. The scientists tracked what happened when beta-hydroxybutyrate attached to the RagC protein and how this affected the mTORC1 pathway, which is a key control system that tells cells whether to grow or stop growing.
The team identified exactly where beta-hydroxybutyrate attaches to RagC (at a specific spot called lysine 349) and discovered which enzymes add and remove this attachment. They used both genetic modifications and chemical analysis to confirm their findings worked the same way in mice and human cancer samples.
This approach allowed researchers to understand the exact molecular mechanism—the step-by-step process—of how diet affects cancer at the cellular level, rather than just observing that it works.
Understanding the exact mechanism is crucial because it shows this isn’t just a coincidence—there’s a real biological reason why a ketogenic diet might help fight cancer. This knowledge could lead to new drugs that mimic this effect or help doctors predict which patients might benefit most from this dietary approach.
The research was conducted by experienced scientists and published in a peer-reviewed journal, meaning other experts reviewed it before publication. The findings were confirmed in multiple ways (in mice and human samples) which increases confidence. However, this is early-stage research, and results in lab settings don’t always translate directly to helping patients. Human clinical trials would be needed to confirm these benefits in real patients.
What the Results Show
The main discovery is that beta-hydroxybutyrate (a chemical your body makes on a ketogenic diet) attaches to a protein called RagC at a very specific location. This attachment is like putting a ‘stop’ sticker on the growth control system of cancer cells. When this happens, the mTORC1 pathway—which normally tells cancer cells to grow—gets turned off.
The researchers found that two enzymes control this process: one enzyme (p300) adds the beta-hydroxybutyrate attachment, and another enzyme (SIRT1) removes it. This is like a light switch that can be turned on and off. When beta-hydroxybutyrate is abundant (from eating a ketogenic diet), more of the ‘stop’ signals get added to RagC.
When RagC has this attachment, it can no longer interact properly with other proteins that would normally activate the cancer growth pathway. This breaks the connection between RagC and the mTORC1 control center, preventing cancer cells from getting the signal to grow.
In mice with colorectal cancer and in human cancer samples, this mechanism successfully slowed cancer growth. The effect was specific to beta-hydroxybutyrate—the other ketone bodies produced during a ketogenic diet (acetoacetate and acetone) did not have the same effect.
The research showed that this mechanism is specific and precise. Only beta-hydroxybutyrate triggered the cancer-fighting effect, not the other ketone bodies produced during ketosis. This specificity is important because it means the benefit comes from a particular chemical signal, not just from general metabolic changes. The findings were consistent across different experimental approaches, suggesting the mechanism is robust and reliable.
Previous research showed that ketogenic diets might help fight cancer, but scientists didn’t understand exactly how. This study fills that gap by identifying the specific molecular mechanism. It builds on earlier work showing that mTORC1 is important in cancer growth and adds new information about how diet can control this pathway. The discovery that RagC acts as a ‘sensor’ for beta-hydroxybutyrate is novel and explains why ketogenic diets might be particularly effective for certain cancers.
This research was done in laboratory settings using mice and human tissue samples in dishes—not in living patients. Results in labs don’t always work the same way in real people with cancer. The study focused specifically on colorectal cancer, so it’s unclear if the same mechanism applies to other cancer types. The research doesn’t tell us the optimal ketogenic diet composition or how long someone would need to follow it. Additionally, this study doesn’t compare the ketogenic diet approach to standard cancer treatments, so we don’t know if it’s better, worse, or should be used alongside conventional therapy.
The Bottom Line
Based on this research (moderate confidence level): If you have colorectal cancer or are at high risk, discuss with your oncologist whether adding a ketogenic diet to your treatment plan might be helpful. This should not replace standard cancer treatments like surgery, chemotherapy, or radiation. The evidence is promising but still preliminary. Consider working with a registered dietitian who understands both ketogenic diets and cancer care.
This research is most relevant to people with colorectal cancer or those at high risk for it. It may also interest people with other cancer types, though the mechanism hasn’t been tested for those. People considering ketogenic diets for cancer prevention should discuss this with their doctor. This is NOT a recommendation for healthy people to adopt a ketogenic diet based solely on this research.
If someone were to try a ketogenic diet as part of cancer treatment, changes in cancer growth would likely take weeks to months to become apparent through medical imaging or blood tests. This is not a quick fix—cancer treatment always requires patience and professional monitoring.
Want to Apply This Research?
- Track daily adherence to ketogenic diet macronutrient targets (percentage of calories from fat, protein, and carbohydrates) and correlate with any available biomarkers like blood ketone levels if monitored by your healthcare provider
- If working with your doctor on a ketogenic diet for cancer management, use the app to log meals, track ketone-friendly foods, monitor carbohydrate intake, and set reminders for consistent meal timing to maintain ketosis
- Maintain a long-term log of diet adherence, energy levels, and any side effects while working closely with your oncology team. Track any medical appointments, test results, and imaging studies to monitor cancer progression alongside dietary changes
This research is preliminary and based on laboratory studies in mice and human tissue samples, not clinical trials in patients. A ketogenic diet should never replace standard cancer treatments recommended by your oncologist. Before making any dietary changes if you have cancer or are at risk for cancer, consult with your oncologist and a registered dietitian. This information is for educational purposes only and should not be considered medical advice. Individual results vary, and what works in a laboratory may not work the same way in living patients.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.